Mangoceuticals (NASDAQ:MGRX) Releases Earnings Results

Mangoceuticals (NASDAQ:MGRX) released its quarterly earnings data on Thursday. The company reported ($1.01) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $0.11 million for the quarter. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%.

Mangoceuticals Price Performance

Shares of NASDAQ:MGRX opened at $4.46 on Friday. The business’s fifty day moving average price is $3.82 and its two-hundred day moving average price is $14.60. Mangoceuticals has a fifty-two week low of $2.07 and a fifty-two week high of $16.80. The stock has a market capitalization of $11.09 million, a price-to-earnings ratio of -0.77 and a beta of 1.51.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.